Skip to main content
. 2020 Sep 22;15(9):e0239401. doi: 10.1371/journal.pone.0239401

Table 2. Predictors of death: Final models.

Variable HR (95%CI) p
WHOLE COHORT (n = 242)
Week-2-MP 0.35 (0.11–1.06) 0.064
Non-pulse glucocorticoids 3.01 (1.28–7.14) 0.012
Hypertension 2.89 (0.91–9.17) 0.072
SpO2/FiO2 0.94 (0.91–0.98) 0.001
CURB65
 Low risk Reference
 Intermediate risk 1.64 (0.55–4.88) 0.371
 High risk 7.72 (2.56–23.26) <0.001
PATIENTS WITH SpO2/FiO2 ≤353 (n = 122)
Week-2-MP 0.31 (0.08–1.12) 0.073
Non-pulse glucocorticoids 2.98 (1.09–8.17) 0.034
Hypertension 3.14 (0.84–11.75) 0.089
SpO2/FiO2 0.92 (0.87-0-97) 0.002
CURB65
 Low risk Reference
 Intermediate risk 1.48 (0.41–5.34) 0.546
 High risk 10.29 (2.72–38.94) 0.001

Week-2-MP: methyl-prednisolone pulses in week 2. HR: hazard ratio; CI: confidence interval.

*HR for SpO2/FiO2 is change in hazard for each increase of 10 units in its value.